Industry: Medical Devices & Consumables
Published Date: 2024-09-15
Pages: 69 Pages
Report ld: 3322004
Request Sample
Customized Report
Fully MagLev Left Ventricular Assist Device (LVAD) Market Size(US$)

CAGR 2024-2030
12.5%
Market Size,2030
USD 2,206
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
A left ventricular assist device (LVAD) is a medical device helps heart pump better when patients have heart failure. Some people use this while waiting for a heart transplant. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. Depending on their location, fully magnetic levitation VADs can generally be divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BiVADs).
The global Fully MagLev Left Ventricular Assist Device (LVAD) market was valued at US$ 943 million in 2023 and is anticipated to reach US$ 2206 million by 2030, witnessing a CAGR of 12.5% during the forecast period 2024-2030.
Currently, the global fully magnetic left levitation ventricular assist device (LVAD) market is monopolized by Abbott's HeartMate 3, which has now become the most commonly used left ventricular assist device (LVAD) in the world, with a market share of over 80%.
From the perspective of the global LVAD device market, the main manufacturer in the United States is Abbott, and full magnetic levitation products have become the absolute mainstream. Competition in Europe is more intense, with more products approved earlier, but they are mainly used the second-generation technology (axial pump). The main player is Berlin heart CmbH.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Fully MagLev Left Ventricular Assist Device (LVAD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fully MagLev Left Ventricular Assist Device (LVAD).
The Fully MagLev Left Ventricular Assist Device (LVAD) market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Fully MagLev Left Ventricular Assist Device (LVAD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fully MagLev Left Ventricular Assist Device (LVAD) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Abbott
Suzhou Tongxin Medical Devices
Shenzhen Core Medical Technology
Segment by Type
Implantable VAD
External VAD
Segment by Application
Bridge-to-transplant (BTT)
Destination Therapy (DT)
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fully MagLev Left Ventricular Assist Device (LVAD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fully MagLev Left Ventricular Assist Device (LVAD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Fully MagLev Left Ventricular Assist Device (LVAD) Market Overview
1.1 Product Definition
1.2 Fully MagLev Left Ventricular Assist Device (LVAD) by Type
1.2.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Market Value Comparison by Type (2024-2030)
1.2.2 Implantable VAD
1.2.3 External VAD
1.3 Fully MagLev Left Ventricular Assist Device (LVAD) by Application
1.3.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Market Value by Application (2024-2030)
1.3.2 Bridge-to-transplant (BTT)
1.3.3 Destination Therapy (DT)
1.3.4 Others
1.4 Global Fully MagLev Left Ventricular Assist Device (LVAD) Market Size Estimates and Forecasts
1.4.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue 2019-2030
1.4.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales 2019-2030
1.4.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fully MagLev Left Ventricular Assist Device (LVAD) Market Competition by Manufacturers
2.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Fully MagLev Left Ventricular Assist Device (LVAD), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fully MagLev Left Ventricular Assist Device (LVAD), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fully MagLev Left Ventricular Assist Device (LVAD), Product Type & Application
2.7 Global Key Manufacturers of Fully MagLev Left Ventricular Assist Device (LVAD), Date of Enter into This Industry
2.8 Global Fully MagLev Left Ventricular Assist Device (LVAD) Market Competitive Situation and Trends
2.8.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Fully MagLev Left Ventricular Assist Device (LVAD) Players Market Share by Revenue
2.8.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Market Scenario by Region
3.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Region: 2019-2030
3.2.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Region: 2019-2024
3.2.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Region: 2025-2030
3.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Region: 2019-2030
3.3.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Region: 2019-2024
3.3.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Region: 2025-2030
3.4 North America Fully MagLev Left Ventricular Assist Device (LVAD) Market Facts & Figures by Country
3.4.1 North America Fully MagLev Left Ventricular Assist Device (LVAD) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Country (2019-2030)
3.4.3 North America Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fully MagLev Left Ventricular Assist Device (LVAD) Market Facts & Figures by Country
3.5.1 Europe Fully MagLev Left Ventricular Assist Device (LVAD) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Country (2019-2030)
3.5.3 Europe Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fully MagLev Left Ventricular Assist Device (LVAD) Market Facts & Figures by Region
3.6.1 Asia Pacific Fully MagLev Left Ventricular Assist Device (LVAD) Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Region (2019-2030)
3.6.3 Asia Pacific Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Fully MagLev Left Ventricular Assist Device (LVAD) Market Facts & Figures by Country
3.7.1 Latin America Fully MagLev Left Ventricular Assist Device (LVAD) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Country (2019-2030)
3.7.3 Latin America Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Fully MagLev Left Ventricular Assist Device (LVAD) Market Facts & Figures by Country
3.8.1 Middle East and Africa Fully MagLev Left Ventricular Assist Device (LVAD) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Type (2019-2030)
4.1.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Type (2019-2024)
4.1.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Type (2025-2030)
4.1.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Market Share by Type (2019-2030)
4.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Type (2019-2030)
4.2.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Type (2019-2024)
4.2.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Type (2025-2030)
4.2.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue Market Share by Type (2019-2030)
4.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Application (2019-2030)
5.1.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Application (2019-2024)
5.1.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales by Application (2025-2030)
5.1.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Market Share by Application (2019-2030)
5.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Application (2019-2030)
5.2.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Application (2019-2024)
5.2.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Application (2025-2030)
5.2.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue Market Share by Application (2019-2030)
5.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Fully MagLev Left Ventricular Assist Device (LVAD) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Fully MagLev Left Ventricular Assist Device (LVAD) Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Suzhou Tongxin Medical Devices
6.2.1 Suzhou Tongxin Medical Devices Company Information
6.2.2 Suzhou Tongxin Medical Devices Description and Business Overview
6.2.3 Suzhou Tongxin Medical Devices Fully MagLev Left Ventricular Assist Device (LVAD) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Suzhou Tongxin Medical Devices Fully MagLev Left Ventricular Assist Device (LVAD) Product Portfolio
6.2.5 Suzhou Tongxin Medical Devices Recent Developments/Updates
6.3 Shenzhen Core Medical Technology
6.3.1 Shenzhen Core Medical Technology Company Information
6.3.2 Shenzhen Core Medical Technology Description and Business Overview
6.3.3 Shenzhen Core Medical Technology Fully MagLev Left Ventricular Assist Device (LVAD) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shenzhen Core Medical Technology Fully MagLev Left Ventricular Assist Device (LVAD) Product Portfolio
6.3.5 Shenzhen Core Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fully MagLev Left Ventricular Assist Device (LVAD) Industry Chain Analysis
7.2 Fully MagLev Left Ventricular Assist Device (LVAD) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fully MagLev Left Ventricular Assist Device (LVAD) Production Mode & Process
7.4 Fully MagLev Left Ventricular Assist Device (LVAD) Sales and Marketing
7.4.1 Fully MagLev Left Ventricular Assist Device (LVAD) Sales Channels
7.4.2 Fully MagLev Left Ventricular Assist Device (LVAD) Distributors
7.5 Fully MagLev Left Ventricular Assist Device (LVAD) Customers
8 Fully MagLev Left Ventricular Assist Device (LVAD) Market Dynamics
8.1 Fully MagLev Left Ventricular Assist Device (LVAD) Industry Trends
8.2 Fully MagLev Left Ventricular Assist Device (LVAD) Market Drivers
8.3 Fully MagLev Left Ventricular Assist Device (LVAD) Market Challenges
8.4 Fully MagLev Left Ventricular Assist Device (LVAD) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Fully MagLev Left Ventricular Assist Device (LVAD) market is projected to grow from US$ 1210 million in 2025 to US$ 2730 million by 2032, at a CAGR of 12.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 119
USD 4900.00
(Single User License)
The global Fully MagLev Left Ventricular Assist Device (LVAD) market size was US$ 1210 million in 2025 and is forecast to reach a readjusted size of US$ 2730 million by 2032 with a CAGR of 12.5% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 67
USD 4250.00
(Single User License)
The global market for Fully MagLev Left Ventricular Assist Device (LVAD) was estimated to be worth US$ 1210 million in 2025 and is projected to reach US$ 2730 million, growing at a CAGR of 12.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 83
USD 3950.00
(Single User License)
The global Fully MagLev Left Ventricular Assist Device (LVAD) market was valued at US$ 1210 million in 2025 and is anticipated to reach US$ 2730 million by 2032, at a CAGR of 12.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 104
USD 2900.00
(Single User License)
The global Fully MagLev Left Ventricular Assist Device (LVAD) market is projected to grow from US$ 1088 million in 2024 to US$ 2454 million by 2031, at a CAGR of 12.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 125
USD 4900.00
(Single User License)
The global Fully MagLev Left Ventricular Assist Device (LVAD) market size was US$ 1088 million in 2024 and is forecast to a readjusted size of US$ 2454 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 74
USD 4250.00
(Single User License)
The global market for Fully MagLev Left Ventricular Assist Device (LVAD) was estimated to be worth US$ 1088 million in 2024 and is forecast to a readjusted size of US$ 2454 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 88
USD 3950.00
(Single User License)
The global market for Fully MagLev Left Ventricular Assist Device (LVAD) was valued at US$ 1088 million in the year 2024 and is projected to reach a revised size of US$ 2454 million by 2031, growing at a CAGR of 12.5% during the forecast period.
Published Date: 2025-03-10
Pages: 76
USD 2900.00
(Single User License)
A left ventricular assist device (LVAD) is a medical device helps heart pump better when patients have heart failure. Some people use this while waiting for a heart transplant. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. Depending on their location, fully magnetic levitation VADs can generally be divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BiVADs).
Published Date: 2024-09-15
Pages: 80
USD 4350.00
(Single User License)
A left ventricular assist device (LVAD) is a medical device helps heart pump better when patients have heart failure. Some people use this while waiting for a heart transplant. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. Depending on their location, fully magnetic levitation VADs can generally be divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BiVADs).
Published Date: 2024-09-15
Pages: 112
USD 4900.00
(Single User License)
The global Fully MagLev Left Ventricular Assist Device (LVAD) market is projected to grow from US$ 1210 million in 2025 to US$ 2730 million by 2032, at a CAGR of 12.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 119
The global Fully MagLev Left Ventricular Assist Device (LVAD) market size was US$ 1210 million in 2025 and is forecast to reach a readjusted size of US$ 2730 million by 2032 with a CAGR of 12.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 67
The global market for Fully MagLev Left Ventricular Assist Device (LVAD) was estimated to be worth US$ 1210 million in 2025 and is projected to reach US$ 2730 million, growing at a CAGR of 12.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 83
The global Fully MagLev Left Ventricular Assist Device (LVAD) market was valued at US$ 1210 million in 2025 and is anticipated to reach US$ 2730 million by 2032, at a CAGR of 12.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 104
The global Fully MagLev Left Ventricular Assist Device (LVAD) market is projected to grow from US$ 1088 million in 2024 to US$ 2454 million by 2031, at a CAGR of 12.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 125
The global Fully MagLev Left Ventricular Assist Device (LVAD) market size was US$ 1088 million in 2024 and is forecast to a readjusted size of US$ 2454 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 74
The global market for Fully MagLev Left Ventricular Assist Device (LVAD) was estimated to be worth US$ 1088 million in 2024 and is forecast to a readjusted size of US$ 2454 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 88
The global market for Fully MagLev Left Ventricular Assist Device (LVAD) was valued at US$ 1088 million in the year 2024 and is projected to reach a revised size of US$ 2454 million by 2031, growing at a CAGR of 12.5% during the forecast period.
Published: 2025-03-10
Pages: 76
A left ventricular assist device (LVAD) is a medical device helps heart pump better when patients have heart failure. Some people use this while waiting for a heart transplant. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. Depending on their location, fully magnetic levitation VADs can generally be divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BiVADs).
Published: 2024-09-15
Pages: 80
A left ventricular assist device (LVAD) is a medical device helps heart pump better when patients have heart failure. Some people use this while waiting for a heart transplant. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. Depending on their location, fully magnetic levitation VADs can generally be divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BiVADs).
Published: 2024-09-15
Pages: 112
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now